Ramelta 8 mg belongs to the generic category of Ramelteon. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Ramelta 8 mg. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Ramelteon and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

*Up to 10% Discount
(Depends on pharmacy)
/ Piece
Ramelta 8 mg may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Ramelta 8 mg is provided below to help users gain a clear understanding of this medicine.
Ramelteon tablet is indicated for the treatment of insomnia characterized by difficulty with sleep onset.
Ramelteon is a melatonin (MT) receptor agonist with both high affinity for melatonin MT1 and MT2 receptors and selectivity over the MT3 receptor. The activity of Ramelteon at the MT1 and MT2 receptors is believed to contribute to its sleep-promoting properties, as these receptors, acted upon by endogenous melatonin, are thought to be involved in the maintenance of the circadian rhythm underlying the normal sleep-wake cycle. Ramelteon has no appreciable affinity for the GABA receptor complex or for receptors that bind to neuropeptides, cytokines, serotonin, dopamine, noradrenaline, acetylcholine and opiates.
Adults: One tablet (8 mg) taken within 30 minutes of going to bed. It should not be taken with or immediately after a high-fat meal. Total daily dose should not exceed 8 mg.Elderly: No overall differences in safety and efficacy between elderly and younger adult subjects.Children: Safety and effectiveness not established.
Rifampin: Decreases exposure to and effects of Ramelteon.
Ketoconazole: Increases AUC for Ramelteon.
Fluconazole: Increases systemic exposure of Ramelteon.
Donepezil: Increases systemic exposure of Ramelteon.
Doxepin: Increases systemic exposure of Ramelteon.
Most common adverse reactions are somnolence, dizziness, fatigue, nausea, headache, and exacerbated insomnia. Hallucinations, behavioral changes such as bizarre behavior, agitation and mania have been reported with Ramelteon use. Amnesia, anxiety and other neuro-psychiatric symptoms may also occur unpredictably
Pregnancy Category C. Based on animal data it may cause fetal harm. Do not use Ramelteon unless the potential benefit justifies the potential risk. It is not known whether Ramelteon is secreted into human milk. Caution should be exercised when administered to a nursing woman.
There may be a chance of occurrence of angioedema, anaphylaxis, hallucinations, decreased testosterone level and increased prolactine level.
Miscellaneous sedatives & hypnotics
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Data Source: Data source of Indications and Usages, Pharmacology, Dosage & Administration, Drug Interactions, Side Effects, Use during Pregnancy & Lactation, Precautions & Warnings, Use in Special Populations, Therapeutic Class, and Storage Conditions is the concerned medicine company or respective organization.
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines

N:B-All Samadhan is a digital healthcare software platform operated by MS Genius Experts. We provide technology solutions for pharmacies and healthcare providers; we are not a direct seller or dispenser of prescription medicines"
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023